Evidence map›Paper›PMID 24161233›Full record

Trial reportThe Lancet. Infectious diseases2014

Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial.

Lennie P G Derde, Ben S Cooper, Herman Goossens, Surbhi Malhotra-Kumar, Rob J L Willems, Marek Gniadkowski, Waleria Hryniewicz, Joanna Empel, Mirjam J D Dautzenberg, Djillali Annane and 14 more

Erratum issued 2 registry-linked trialsAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Lancet. Infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 2 registered trials, which are not on this map. Cited by 119 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
119citing papers in PubMed, 7 pooled it
24.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00976638 nacompletednot on this map

Mastering Hospital Antibiotic Resistance, a Cluster Randomized Intervention Study in Intensive Care Units Throughout Europe (Work Package 3)

TypeinterventionalSponsorUMC UtrechtRan2008 to 2011Enrolled14,318ConditionsHospital Acquired InfectionsArmsChromogenic surveillance, Molecular surveillance
NCT03268122 nacompletednot on this mapstarted 2017, after this paper: background citation

Comparison of Standard Isolation With Targeted Isolation for Preventing Nosocomial Transmission of MRSA and VRE: A Pilot Clinical Trial

TypeinterventionalSponsorVanderbilt University Medical CenterRan2017 to 2018Enrolled1,974ConditionsMRSA, VRE InfectionArmsStandard Contact Isolation, Targeted Contact Isolation
3 · Its place in the literature

Who cites it

119 citing papers in PubMed, 7 syntheses or guidelines pooled it, 353 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Interventions to improve hand hygiene compliance in patient care.The Cochrane database of systematic reviews · 2017
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Article
  19. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2025
    Article
  20. Article

59 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 17 institutions in 12 countries.

Lennie P G DerdeDepartment of Intensive Care Medicine, University Medical Center Utrecht, Utrecht, Netherlands. Electronic address: lderde@umcutrecht.nl.
Ben S CooperCentre for Clinical Vaccinology and Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Herman GoossensDepartment of Medical Microbiology, Vaccine & Infectious Disease Institute, Antwerp University, University Hospital Antwerp, Antwerp, Belgium.
Surbhi Malhotra-KumarDepartment of Medical Microbiology, Vaccine & Infectious Disease Institute, Antwerp University, University Hospital Antwerp, Antwerp, Belgium.
Rob J L WillemsDepartment of Medical Microbiology, University Medical Center Utrecht, Utrecht, Netherlands.
Marek GniadkowskiDepartment of Molecular Microbiology, National Medicines Institute, Warsaw, Poland.
Waleria HryniewiczDivision of Microbiology and Infection Prevention, National Medicines Institute, Warsaw, Poland.
Joanna EmpelDepartment of Molecular Microbiology, National Medicines Institute, Warsaw, Poland.
Mirjam J D DautzenbergJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands.
Djillali AnnaneService de Réanimation Médicale, Hôpital Raymond Poincaré, Garches, France.
Irene AragãoPolyvalent Intensive Care Unit, Central Hospital of Porto, Porto, Portugal.
Annie ChalfineInfection Control Unit, Groupe Hospitalier Paris-Saint Joseph, Paris, France.
Uga DumpisDepartment of Infection Control, Paul Stradins University Hospital, Riga, Latvia.
Francisco EstevesICU and Emergency Department, Centro Hospitalar Trás-os-Montes e Alto Douro, Vila Real, Portugal.
Helen Giamarellou4th Department of Internal Medicine, Athens University Medical School, Attikon General Hospital, Athens, Greece.
Igor MuzlovicClinic for Infectious Diseases and Febrile Illnesses, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Giuseppe NardiShock and Trauma Unit, Intensive Care Unit, Azienda Ospedaliera S Camillo Forlanini, Rome, Italy.
George L PetrikkosInfectious Diseases Unit, Laikon General Hospital, University of Athens, Athens, Greece.
Viktorija TomicLaboratory for Respiratory Microbiology, University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia.
Antonio Torres MartíPneumology Department, Hospital Clinic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Ciber de Enfermedades Respiratorias, University of Barcelona, Barcelona, Spain.
Pascal StammetIntensive Care Unit, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg.
Christian Brun-BuissonService de réanimation médicale and INSERM U657, Institut Pasteur, APHP GH Henri Mondor, Université Paris Est-Créteil, Creteil, France.
Marc J M BontenDepartment of Medical Microbiology, University Medical Center Utrecht, Utrecht, Netherlands; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands.
MOSAR WP3 Study Team
University Medical Center Utrecht · NLNarodowy Instytut Leków · PLAntwerp University Hospital · BEAzienda Ospedaliera San Camillo-Forlanini · ITCentre Hospitalier de Luxembourg · LUCentro Hospitalar de Trás os Montes e Alto Douro · PTCUF Porto Hospital · PTHôpital Paris Saint-Joseph · FRHôpital Raymond-Poincaré · FRInstitut Pasteur · FRLjubljana University Medical Centre · SINational and Kapodistrian University of Athens · GRPauls Stradiņš Clinical University Hospital · LVUniversitat de Barcelona · ESUniversity Clinic of Pulmonary and Allergic Diseases Golnik · SIUniversity General Hospital Attikon · GRUniversity of Oxford · GB

Funding

Medical Research Council MR/K006924/1Wellcome TrustWellcome Trust 089275/Z/09/Z
6 · The paper itself

Abstract

backgroundIntensive care units (ICUs) are high-risk areas for transmission of antimicrobial-resistant bacteria, but no controlled study has tested the effect of rapid screening and isolation of carriers on transmission in settings with best-standard precautions. We assessed interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in European ICUs.

methodsWe did this study in three phases at 13 ICUs. After a 6 month baseline period (phase 1), we did an interrupted time series study of universal chlorhexidine body-washing combined with hand hygiene improvement for 6 months (phase 2), followed by a 12-15 month cluster randomised trial (phase 3). ICUs were randomly assigned by computer generated randomisation schedule to either conventional screening (chromogenic screening for meticillin-resistant Staphylococcus aureus [MRSA] and vancomycin-resistant enterococci [VRE]) or rapid screening (PCR testing for MRSA and VRE and chromogenic screening for highly resistant Enterobacteriaceae [HRE]); with contact precautions for identified carriers. The primary outcome was acquisition of resistant bacteria per 100 patient-days at risk, for which we calculated step changes and changes in trends after the introduction of each intervention. We assessed acquisition by microbiological surveillance and analysed it with a multilevel Poisson segmented regression model. We compared screening groups with a likelihood ratio test that combined step changes and changes to trend. This study is registered with ClinicalTrials.gov, number NCT00976638.

findingsSeven ICUs were assigned to rapid screening and six to conventional screening. Mean hand hygiene compliance improved from 52% in phase 1 to 69% in phase 2, and 77% in phase 3. Median proportions of patients receiving chlorhexidine body-washing increased from 0% to 100% at the start of phase 2. For trends in acquisition of antimicrobial-resistant bacteria, weekly incidence rate ratio (IRR) was 0·976 (0·954-0·999) for phase 2 and 1·015 (0·998-1·032) for phase 3. For step changes, weekly IRR was 0·955 (0·676-1·348) for phase 2 and 0·634 (0·349-1·153) for phase 3. The decrease in trend in phase 2 was largely caused by changes in acquisition of MRSA (weekly IRR 0·925, 95% CI 0·890-0·962). Acquisition was lower in the conventional screening group than in the rapid screening group, but did not differ significantly (p=0·06).

interpretationImproved hand hygiene plus unit-wide chlorhexidine body-washing reduced acquisition of antimicrobial-resistant bacteria, particularly MRSA. In the context of a sustained high level of compliance to hand hygiene and chlorhexidine bathings, screening and isolation of carriers do not reduce acquisition rates of multidrug-resistant bacteria, whether or not screening is done with rapid testing or conventional testing.

fundingEuropean Commission.

Indexed as

Intensive Care UnitsAgedBacterial InfectionsCarrier StateChlorhexidineCross InfectionDisease Transmission, InfectiousDisinfectantsEnterobacteriaceaeEnterococcusFemaleHand DisinfectionHumansIncidenceInfection ControlMaleChlorhexidineDisinfectants

Identifiers

PMID24161233
PMCPMC3895323
OpenAlexW2136443076

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.